Advanced search
Publication Cover
Platelets Volume 16, 2005 - Issue 2
Submit an article Journal homepage
142
Views
37
CrossRef citations to date
0
Altmetric
Original Article

Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes

Miles W. H. Behan Division of Cardiovascular Medicine, Queens Medical Centre, Nottingham, UK
,
Susan C. Fox Division of Cardiovascular Medicine, Queens Medical Centre, Nottingham, UKCorrespondence[email protected]
,
Stan Heptinstall Division of Cardiovascular Medicine, Queens Medical Centre, Nottingham, UK
&
Robert F. Storey Cardiovascular Research Group, Northern General Hospital, Sheffield, UK
Pages 73-80 | Received 30 Jun 2004, Accepted 12 Jul 2004, Published online: 07 Jul 2009

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Jingru Chen, Miao Wang, Ying Zhang, Fenglin Zhu, Yanqiu Xu, Guoxiang Yi, Runxiu Zheng & Bin Wu. (2023) Platelet extracellular vesicles: Darkness and light of autoimmune diseases. International Reviews of Immunology 0:0, pages 1-11.
Read now
Aleksandra Gasecka, Rienk Nieuwland, Monika Budnik, Françoise Dignat-George, Ceren Eyileten, Paul Harrison, Zenon Huczek, Agnieszka Kapłon-Cieślicka, Romaric Lacroix, Grzegorz Opolski, Kinga Pluta, Edwin van der Pol, Marek Postuła, Aurélie Leroyer, Pia Siljander, Auguste Sturk & Krzysztof J. Filipiak. (2020) Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction. Platelets 31:1, pages 26-32.
Read now
Tesse C. Leunissen, Peter Paul Wisman, Thijs C. van Holten, Philip G. de Groot, Suzanne J. Korporaal, Arnold C. Koekman, Frans L. Moll, Martin Teraa, Marianne C. Verhaar, Gert Jan de Borst, Rolf T. Urbanus & Mark Roest. (2017) The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays. Platelets 28:6, pages 567-575.
Read now
Stan Heptinstall$suffix/text()$suffix/text(), David Iyu Espinosa, Panagiotis Manolopoulos, Jackie R. Glenn, Ann E. White, Andrew Johnson, Natalia Dovlatova, Sue C. Fox, Jane A. May, David Hermann, Olafur Magnusson, Kari Stefansson, Dan Hartman & Mark Gurney. (2008) DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease. Platelets 19:8, pages 605-613.
Read now
P. Manolopoulos, J. R. Glenn, S. C. Fox, J. A. May, N. L. Dovlatova, S.-W. Tang, N. R. Thomas, V. Ralevic & S. Heptinstall. (2008) Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: A new finding that may influence the design of anti-thrombotic agents. Platelets 19:2, pages 134-145.
Read now
Heather M. Judge, Robert J. Buckland, Atsuhiro Sugidachi, Joseph A. Jakubowski & Robert F. Storey. (2008) The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses. Platelets 19:2, pages 125-133.
Read now

Articles from other publishers (31)

Alba Vilella-Figuerola, Alberto Cordero, Sònia Mirabet, Natàlia Muñoz-García, Rosa Suades, Teresa Padró & Lina Badimon. (2023) Platelet-Released Extracellular Vesicle Characteristics Differ in Chronic and in Acute Heart Disease. Thrombosis and Haemostasis 123:09, pages 892-903.
Crossref
Matthew T. Harper. 2023. Extracellular Vesicles in Cardiovascular and Metabolic Diseases. Extracellular Vesicles in Cardiovascular and Metabolic Diseases 259 275 .
Valentina Carotti, Juan P. Rigalli, Jenny van Asbeck-van der Wijst & Joost G.J. Hoenderop. (2022) Interplay between purinergic signalling and extracellular vesicles in health and disease. Biochemical Pharmacology 203, pages 115192.
Crossref
Lei Zhang, Zhen Li, Xianren Ye, Zhuo Chen & Zhe-Sheng Chen. (2021) Mechanisms of thrombosis and research progress on targeted antithrombotic drugs. Drug Discovery Today 26:10, pages 2282-2302.
Crossref
Konstantinos Zifkos, Christophe Dubois & Katrin Schäfer. (2021) Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence. International Journal of Molecular Sciences 22:17, pages 9317.
Crossref
Angela Dziedzic, Elzbieta Miller, Joanna Saluk-Bijak, Marta Niwald & Michal Bijak. (2021) The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y12 Pathway in Multiple Sclerosis. International Journal of Molecular Sciences 22:12, pages 6572.
Crossref
Aleksandra Gąsecka, Sylwester Rogula, Ceren Eyileten, Marek Postuła, Miłosz J. Jaguszewski, Janusz Kochman, Tomasz Mazurek, Rienk Nieuwland & Krzysztof J. Filipiak. (2020) Role of P2Y Receptors in Platelet Extracellular Vesicle Release. International Journal of Molecular Sciences 21:17, pages 6065.
Crossref
Henry Nording, Lasse Baron & Harald F. Langer. (2020) Platelets as therapeutic targets to prevent atherosclerosis. Atherosclerosis 307, pages 97-108.
Crossref
S. R. Gilyarevskiy. (2020) Latent opportunities for the prevention of ischemic stroke in patients with atherosclerosis-related diseases: additional analysis of randomized trials on rivaroxaban. Russian Journal of Cardiology 25:2, pages 81-89.
Crossref
Aleksandra Gasecka, Rienk Nieuwland, Monika Budnik, Françoise Dignat‐George, Ceren Eyileten, Paul Harrison, Romaric Lacroix, Aurélie Leroyer, Grzegorz Opolski, Kinga Pluta, Edwin van der Pol, Marek Postuła, Pia Siljander, Jolanta M. Siller‐Matula & Krzysztof J. Filipiak. (2020) Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel. Journal of Thrombosis and Haemostasis 18:3, pages 609-623.
Crossref
Francesco Taus, Alessandra Meneguzzi, Marco Castelli & Pietro Minuz. (2019) Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?. Frontiers in Pharmacology 10.
Crossref
Marta Zarà, Gianni Francesco Guidetti, Marina Camera, Ilaria Canobbio, Patrizia Amadio, Mauro Torti, Elena Tremoli & Silvia Stella Barbieri. (2019) Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis. International Journal of Molecular Sciences 20:11, pages 2840.
Crossref
Paul A. GurbelKeith A.A. FoxUdaya S. TantryHugo ten CateJeffrey I. Weitz. (2019) Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease. Circulation 139:18, pages 2170-2185.
Crossref
Hao Wei, Jean-Daniel M. Malcor & Matthew T. Harper. (2018) Lipid rafts are essential for release of phosphatidylserine-exposing extracellular vesicles from platelets. Scientific Reports 8:1.
Crossref
Mariusz Tomaniak, Aleksandra Gąsecka & Krzysztof J. Filipiak. (2017) Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring — A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application. International Journal of Cardiology 226, pages 93-102.
Crossref
Alice Giacomazzi, Maurizio Degan, Stefano Calabria, Alessandra Meneguzzi & Pietro Minuz. (2016) Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles. Frontiers in Pharmacology 7.
Crossref
Eitan A. Friedman, Luisa Texeira, Jessica Delaney, Peter E. Weeke, Donald R. LynchJr.Jr., Ehab Kasasbeh, Yanna Song, Frank E. HarrellJr.Jr., Josh C. Denny, Heidi E. Hamm, Dan M. Roden & John H. Cleator. (2015) Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis 41:4, pages 656-662.
Crossref
John H. Cleator, Matthew T. Duvernay, Michael Holinstat, Nancy E. Colowick, Willie J. Hudson, Yanna Song, Frank E. Harrell & Heidi E. Hamm. (2014) Racial Differences in Resistance to P2Y 12 Receptor Antagonists in Type 2 Diabetic Subjects . Journal of Pharmacology and Experimental Therapeutics 351:1, pages 33-43.
Crossref
Partha Sardar, Ramez Nairooz, Saurav Chatterjee, Savi Mushiyev, Gerald Pekler & Ferdinand Visco. (2013) Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials. Journal of Thrombosis and Thrombolysis 38:1, pages 1-10.
Crossref
Yanjun Zhang, Xiao Liu, Li Liu, Ana-Maria Zaske, Zhou Zhou, Yuanyuan Fu, Xi Yang, Jodie Conyers, Min Li, Jing-fei Dong & Jianning Zhang. (2017) Contact- and agonist-regulated microvesiculation of human platelets. Thrombosis and Haemostasis 110:08, pages 331-399.
Crossref
Wen-Chao Ou, Yun Zhong, Ben-Rong Liu, Shi-Ming Liu, Hai-Feng Chen & Ke-Ji Chen. (2012) Inhibition of Platelet Activation and Aggregation by Furostanol Saponins Isolated From the Bulbs of Allium macrostemon Bunge. The American Journal of the Medical Sciences 344:4, pages 261-267.
Crossref
Elisabetta Volpi, Laura Giusti, Federica Ciregia, Ylenia Da Valle, Gino Giannaccini, Sergio Berti, Aldo Clerico & Antonio Lucacchini. (2012) Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention. Clinical Biochemistry 45:10-11, pages 758-765.
Crossref
Paul A. Gurbel, Kevin P. Bliden, Mark J. Antonino, Tania Gesheff, Charles C. Cummings, Benjamin V. Dubois, William R. Herzog & Udaya S. Tantry. (2012) Time dependence of clopidogrel loading effect: Platelet activation versus platelet aggregation. Thrombosis Research 129:1, pages 1-2.
Crossref
Robert A. Harrington, Gregg W. Stone, Steven McNulty, Harvey D. White, A. Michael Lincoff, C. Michael Gibson, Charles V. PollackJr.Jr., Gilles Montalescot, Kenneth W. Mahaffey, Neal S. Kleiman, Shaun G. Goodman, Maged Amine, Dominick J. Angiolillo, Richard C. Becker, Derek P. Chew, William J. French, Franz Leisch, Keyur H. Parikh, Simona Skerjanec & Deepak L. Bhatt. (2009) Platelet Inhibition with Cangrelor in Patients Undergoing PCI. New England Journal of Medicine 361:24, pages 2318-2329.
Crossref
Y.N. KOTOVA, F.I. ATAULLAKHANOV & M.A. PANTELEEV. (2008) Formation of coated platelets is regulated by the dense granule secretion of adenosine 5′diphosphate acting via the P2Y12 receptor. Journal of Thrombosis and Haemostasis 6:9, pages 1603-1605.
Crossref
Marie Lordkipanidzé, Chantal Pharand, Thuy Anh Nguyen, Erick Schampaert & Jean G Diodati. (2008) Assessment of VerifyNow P2Y12 Assay Accuracy in Evaluating Clopidogrel-Induced Platelet Inhibition. Therapeutic Drug Monitoring 30:3, pages 372-378.
Crossref
A.L. FRELINGERIIIIII, J.A. JAKUBOWSKI, Y. LI, M.R. BARNARD, M.D. LINDEN, I. TARNOW, M.L. FOX, A. SUGIDACHI, K.J. WINTERS, M.I. FURMAN & A.D. MICHELSON. (2008) The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. Journal of Thrombosis and Haemostasis 6:2, pages 359-365.
Crossref
A. L. FRELINGER, J. A. JAKUBOWSKI, Y. LI, M. R. BARNARD, M. D. LINDEN, I. TARNOW, M. L. FOX, A. SUGIDACHI, K. J. WINTERS, M. I. FURMAN & A. D. MICHELSON. (2008) The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. Journal of Thrombosis and Haemostasis 6:2, pages 359-365.
Crossref
H.M. Mardikar, M.S. Hiremath, David J. Moliterno, Rony Mathew, Rangolee Arora, Dhananjay Deo, J.S. Hiremath, N.V. Deshpande, Aziz Khan, Jacob Joseph & Debabrata Mukherjee. (2007) Optimal platelet inhibition in patients undergoing PCI: Data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) study. American Heart Journal 154:2, pages 344.e1-344.e5.
Crossref
Wolfgang Lösche & Stan Heptinstall. (2007) Value of Platelet Activation Markers as Prothrombotic Risk Indicators. Transfusion Medicine and Hemotherapy 34:1, pages 34-42.
Crossref
Aparna R. Dalal, Stanlies D’;Souza & Mark S. Shulman. (2006) Brief review: Coronary drug-eluting stents and anesthesiaArticle de synthèse court: Les tuteurs coronariens actifs et l’anesthésie. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 53:12, pages 1230-1243.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.